Orum Therapeutics, Inc. (KOSDAQ:475830)
56,800
+200 (0.35%)
Nov 20, 2025, 3:30 PM KST
0.35% (1Y)
| Market Cap | 1.20T |
| Revenue (ttm) | 20.88B |
| Net Income (ttm) | -8.83B |
| Shares Out | 21.16M |
| EPS (ttm) | -675.12 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 199,486 |
| Average Volume | 332,499 |
| Open | 56,600 |
| Previous Close | 56,600 |
| Day's Range | 55,000 - 57,600 |
| 52-Week Range | 15,950 - 60,200 |
| Beta | n/a |
| RSI | 71.57 |
| Earnings Date | Nov 14, 2025 |